NCT01825005View on ClinicalTrials.gov

Predicting Outcome in Cervix Carcinoma: a Prospective Study

CompletedOBSERVATIONAL
Enrollment

423

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
Cervical Cancer
Trial Locations (2)

Unknown

Maastricht University Hospital, Maastricht

Bloemfontein medicross, Bloemfontein

All Listed Sponsors
lead

Maastricht Radiation Oncology

OTHER

NCT01825005 - Predicting Outcome in Cervix Carcinoma: a Prospective Study | Biotech Hunter | Biotech Hunter